SCHEMBL24258224

SCHEMBL24258224

Nc1cccc2c1OCCC21CC1

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24258176 0.93 HTR6 (0.33) HTR6
SCHEMBL21936943 0.83 CD44 (0.30)
SCHEMBL31304876 0.83 CD44 (0.30)
SCHEMBL21845453 0.78 HTR2C (0.33)
SCHEMBL15709840 0.78 ADRA2A (0.33)
SCHEMBL15709552 0.76
SCHEMBL24258222 0.76
SCHEMBL21750748 0.76 HTR6 (0.32) HTR6
SCHEMBL21845442 0.75 LMNA (0.35)
SCHEMBL30983155 0.75 PARP1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3860714-B1 11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN SITEONE THERAPEUTICS INC (US) 2023-09-06 EP disclosed
WO-2022036297-A1 NON-HYDRATED KETONE INHIBITORS OF NAV1.7 FOR THE TREATMENT OF PAIN SITEONE THERAPEUTICS, INC. (US) 2022-02-17 WO disclosed